‹ All Posts
AALGO BREATHS I SEBI RA

22nd Aug · SEBI-Registered Analyst

WOCKHARDT PHARMA SUPPORT ZONE SETUP DISCUSSION

WOCKPHARMA
Wockhardt Pharma is currently consolidating around an important support area, where repeated buying interest is visible. The recent price structure indicates a possible base formation, while momentum remains cautious. A decisive breakout above the resistance zone could improve the short-term technical outlook. 🔎 TECHNICAL VIEW: • Stock is consolidating near the ₹1,843 support zone • Repeated attempts to hold lower levels indicate buyer interest • A triple-bottom type structure appears to be developing • Momentum is currently cautious, but recovery potential remains • Sustained strength above resistance can provide confirmation of a bullish move • Traders should watch price action and volume for breakout confirmation 🔑 KEY LEVELS: 🟢 Support Zone: ₹1,843–₹1,793 🔴 Resistance Zone: ₹1,893–₹1,943 🚀 POTENTIAL UPSIDE LEVELS: 🎯 ₹2,031 🎯 ₹2,145 🎯 ₹2,297+ 📈 BULLISH TRIGGER: A sustained move above ₹1,943, preferably supported by strong price action and volume, could signal fresh buying momentum. If the breakout sustains, the stock may gradually move toward the next resistance/target zones of ₹2,031 → ₹2,145 → ₹2,297+. 📉 RISK / INVALIDATION: A decisive breakdown below ₹1,793 may weaken the current base-formation setup and could invite further selling pressure. Proper risk management is therefore important. 👀 WHAT TO WATCH: The immediate focus remains on whether the stock can continue to defend ₹1,843–₹1,793 and reclaim ₹1,893–₹1,943 with strength. A successful breakout could improve the overall short-term structure. ⚠️ DISCLAIMER: For educational and informational purposes only. This is not a buy/sell recommendation or investment advice. Please conduct your own research and consult a SEBI-registered investment adviser before making any investment decision. — AALGO BREATHS 📊

#EquityResearch#PersonalFinance#FundamentalViews#TechnicalViews#StockInNews
photo_2026-08-21_12-14-53.jpg
786 likes·53 comments